Free CCRC Detailed Role Questions and Answers

Question 1

Which of the following scenarios are considered SAEs?

Accepted Answer

infection following surgery prolonging hospital stay

Answer

A Serious Adverse Event (SAE) is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, or is a congenital anomaly/birth defect. An infection following surgery that prolongs a subject's hospital stay directly meets the criterion of 'prolongation of existing hospitalization,' thus qualifying as an SAE.

Question 2

Which of the following are responsibilities of an IDMC/DSMB

Accepted Answer

assess the progress of a trial

Answer

An Independent Data Monitoring Committee (IDMC) or Data Safety Monitoring Board (DSMB) is an independent group of experts that periodically reviews accumulating data from an ongoing clinical trial. Their primary responsibilities include assessing the safety and efficacy data, monitoring the overall progress of the trial, and making recommendations to the sponsor regarding the continuation, modification, or termination of the study. They ensure the ethical conduct and scientific integrity of the trial.

Question 3

The trough blood level for a once-daily drug should be drawn how long after the dose?

Accepted Answer

24 hours

Answer

The trough blood level of a drug represents its lowest concentration in the bloodstream, typically occurring just before the next dose is administered. For a once-daily drug, this means the trough level should be drawn approximately 24 hours after the previous dose. This measurement is crucial for determining if the drug concentration remains within the therapeutic window and for assessing patient compliance.

Question 4

A CRA calls a CRC to schedule the final monitoring visit. The sponsor requires that the PI be present. The only dates available for the CRA conflict with the PI's schedule. To prepare for the visit, the CRC should:

Accepted Answer

reschedule the visit

Answer

If the sponsor requires the Principal Investigator (PI) to be present for a final monitoring visit and the available dates conflict with the PI's schedule, the CRC's primary responsibility is to ensure compliance with the sponsor's requirements. The most appropriate action is to reschedule the visit to a time when the PI can be present. This ensures all necessary parties are available for the comprehensive review and discussion required at a close-out visit.

Question 5

A CRA is conducting a close-out visit at a site to review the regulatory documents. The CRC has prepared the following documents to be filed and/or sent to the sponsor: treatment decoding documentation code list, documentation of IP destruction and final report to the IRB/IEC. Which of the following actions should the CRC perform?

Accepted Answer

Send the treatment decoding documentation to the sponsor

Answer

During a close-out visit, the CRC must ensure all required documents are properly filed and submitted according to sponsor and regulatory guidelines. The treatment decoding documentation (e.g., randomization code list) is crucial for the sponsor to unblind the study data and is typically sent to them. Subject identification code lists should be retained at the site to protect subject privacy, and drug accountability logs are usually retained by the site for audit purposes, with copies of destruction forms sent to the sponsor.

CCRC - Certified Clinical Research Coordinator Practice Test

CCRC - Certified Clinical Research Coordinator Practice Test

Free CCRC Detailed Role Questions and Answers